Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
54.35B
Market cap54.35B
Price-Earnings ratio
51.27
Price-Earnings ratio51.27
Dividend yield
Dividend yield
Average volume
5.13M
Average volume5.13M
High today
$94.47
High today$94.47
Low today
$91.82
Low today$91.82
Open price
$92.00
Open price$92.00
Volume
3.13M
Volume3.13M
52 Week high
$94.47
52 Week high$94.47
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

Edwards Lifesciences(EW) stock is priced at $94.37, giving the company a market capitalization of 54.35B. It carries a P/E multiple of 51.27.

On 2026-07-04, Edwards Lifesciences(EW) stock moved within a range of $91.82 to $94.47. With shares now at $94.37, the stock is trading +2.8% above its intraday low and -0.1% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 3.13M, versus its average volume of 5.13M.

The stock's 52-week range extends from a low of $72.30 to a high of $94.47.

The stock's 52-week range extends from a low of $72.30 to a high of $94.47.

EW News

MarketWatch 1d
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

...

Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
TipRanks 4d
Edwards Lifesciences price target raised to $110 from $100 at BTIG

BTIG analyst Marie Thibault raised the firm’s price target on Edwards Lifesciences (EW) to $110 from $100 and keeps a Buy rating on the shares. Edwards Lifescie...

Simply Wall St 5d
Is Edwards Lifesciences Below Fair Value Following New York Valves Trial Data?

Edwards Lifesciences (EW) has drawn fresh attention after unveiling extensive clinical data at the New York Valves 2026 conference. The company highlighted resu...

Is Edwards Lifesciences Below Fair Value Following New York Valves Trial Data?

Analyst ratings

72%

of 32 ratings
Buy
71.9%
Hold
28.1%
Sell
0%

More EW News

Simply Wall St 7d
How New Structural Heart Data from TAVR and PASCAL Will Impact Edwards Lifesciences Investors

Earlier this week, Edwards Lifesciences reported new clinical data at the New York Valves 2026 conference, including PROGRESS trial baseline results in moderate...

How New Structural Heart Data from TAVR and PASCAL Will Impact Edwards Lifesciences Investors

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.